Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 2D-to-3D Culture and Organoids 2020

Jennifer Rosenbluth's Biography



Jennifer Rosenbluth, Instructor in Medicine, Dana-Farber Cancer Institute

Dr. Rosenbluth received her undergraduate degree from Princeton University, and her MD and PhD from Vanderbilt University School of Medicine. She then completed her residency in Internal Medicine at Massachusetts General Hospital, and her Oncology fellowship at Dana-Farber Cancer Institute. Dr. Rosenbluth is a medical oncologist in the breast cancer program at Dana-Farber Cancer Institute. She also performs research at Harvard Medical School, where she uses model systems to understand the development of aggressive forms of breast cancer and to test new therapies.

Jennifer Rosenbluth Image

Modeling Cancer Prevention In Breast Organoids

Thursday, 26 March 2020 at 09:00

Add to Calendar ▼2020-03-26 09:00:002020-03-26 10:00:00Europe/LondonModeling Cancer Prevention In Breast Organoids2D-to-3D Culture and Organoids 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Mammary organoids can be used to preserve complex lineages in long-term culture.  Using mass cytometry to profile cell states in patient-derived breast organoids, we identify a cell population that is expanded in the breast tissue of BRCA1/2 mutation carriers.  This approach is being extended to model early stages of cancer development as well as aggressive breast cancer subtypes.


Add to Calendar ▼2020-03-25 00:00:002020-03-26 00:00:00Europe/London2D-to-3D Culture and Organoids 20202D-to-3D Culture and Organoids 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com